Bottom line
How has RSVAX performed?
As of Dec 31, 2025, RSVAX returned −1.4% over the past year, +8.1% a year over five years, +8.2% a year over ten years. That means $10,000 invested ten years earlier would have grown to about $21,900. Its five-year return beat 12% of large value funds we track. Its best quarter was +21.2% and its worst −32.4%.
Updated Dec 31, 2025
RSVAX annual returns by year
| Year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| RSVAX | +4.7% | +12.6% | +7.5% | −3.0% | +27.3% | −2.6% | +31.4% | −10.8% | +17.4% | +10.9% |
Source: Fund prospectus bar chart (risk/return summary)
Growth of $10,000 in RSVAX
$10,000 invested at the start of 2016 would have been worth about $23,300 by the end of 2025, based on the fund's reported calendar-year returns.
| Year | Return | Value of $10,000 |
|---|---|---|
| 2025 | +4.7% | $23,281 |
| 2024 | +12.6% | $22,247 |
| 2023 | +7.5% | $19,752 |
| 2022 | −3.0% | $18,371 |
| 2021 | +27.3% | $18,933 |
| 2020 | −2.6% | $14,872 |
| 2019 | +31.4% | $15,267 |
| 2018 | −10.8% | $11,623 |
| 2017 | +17.4% | $13,023 |
| 2016 | +10.9% | $11,092 |
Trailing returns vs benchmark and category
| 1 yr | 5 yr | 10 yr | Since inception | |
|---|---|---|---|---|
| RSVAX | −1.4% | +8.1% | +8.2% | — |
| Large Value median | +13.6% | +11.3% | +10.2% | — |
Source: Prospectus as of Dec 31, 2025; category medians computed by MutualFund.com
Recent monthly returns
For the three months ending Jun 30, 2026, RSVAX returned +6.07%, −1.43%, +1.37% (oldest to newest), per SEC Form N-PORT.
Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.